Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.40 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.40 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.40 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.40 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.40 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.40 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.40 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.40 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.40 |
| ▸ | PSMA5 | P28066 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18796610 | 1.00 | SLC6A5 (0.48) | SLC6A5HDAC2TAS1R3TAS1R1NOD1 | |
| SCHEMBL6562051 | 1.00 | SLC6A5 (0.48) | SLC6A5HDAC2TAS1R3TAS1R1NOD1 | |
| SCHEMBL8400344 | 0.99 | SLC6A5 (0.46) | SLC6A5HDAC2TAS1R3TAS1R1NOD1 | |
| SCHEMBL8400342 | 0.99 | SLC6A5 (0.46) | SLC6A5HDAC2TAS1R3TAS1R1NOD1 | |
| SCHEMBL31026963 | 0.90 | CNR1 (0.50) | SLC6A5HDAC2FAAHPPARG | |
| SCHEMBL8399325 | 0.86 | HDAC2 (0.47) | HDAC2TAS1R3TAS1R1 | |
| SCHEMBL8399320 | 0.86 | HDAC2 (0.47) | HDAC2TAS1R3TAS1R1 | |
| SCHEMBL15846206 | 0.84 | SLC6A5 (0.53) | SLC6A5NOD1FAAHLMNAPPARG | |
| SCHEMBL15846639 | 0.84 | SLC6A5 (0.53) | SLC6A5NOD1FAAHLMNAPPARG | |
| SCHEMBL28739398 | 0.84 | SLC6A5 (0.53) | SLC6A5NOD1FAAHLMNAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3511318-A1 | IMMUNOSTIMULATING AGENT | AJINOMOTO CO., INC. (JP) | 2019-07-17 | — | — | EP | disclosed |
| EP-3368508-A1 | IMMUNOSTIMULATING AGENT | AJINOMOTO CO., INC. (JP) | 2018-09-05 | — | — | EP | disclosed |
| US-20180243421-A1 | IMMUNOSTIMULATING AGENT | AJINOMOTO CO., INC. (JP) | 2018-08-30 | — | — | US | disclosed |
| WO-2017073797-A1 | IMMUNOSTIMULATING AGENT | AJINOMOTO CO., INC. (JP) | 2017-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180243421-A1 | IMMUNOSTIMULATING AGENT | MYD88, IL2, IFNG | SLC6A5 4504/4885HDAC2 1130/4885TAS1R3 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.